00860nas a2200229   4500000000100000000000100001008004100002260007000043653001700113653002000130653002100150653001500171100001300186700001400199700001200213700001100225245011300236300001000349490000800359520024900367022001400616       2011                            d  c01/2011bSchlütersche Verlagsgesellschaft mbH & Co. KGaHannover10aparvovirosis10achallenge study10across-protection10aVanguard 71 aE Siedek1 aH Schmidt1 aG Sture1 aR Raue00aVaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c  a58-640 v1243 aMutations in canine parvovirus (CPV) field isolates have created concerns regardingthe ability of vaccines containing CPV-2 to protect against infection with thenewly identified antigenic types CPV-2b and CPV-2c. To address this concern,the ...  a0005-9366